H-VLDGLDVLL^-OH

Ref. 3D-PP48352

Produktinformation

• Name: H-VLDGLDVLL^-OH

Beschreibung

Peptide H-VLDGLDVLL^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VLDGLDVLL^-OH include the following: PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer RA van Amerongen, S Tuit, AK Wouters - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1121973/full Human γΎ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells N Himoudi, DA Morgenstern , M Yan - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/188/4/1708/39283 Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes JH Kessler, S Khan, U Seifert, S Le Gall, KM Chow - Nature , 2011 - nature.comhttps://www.nature.com/articles/ni.1974 Efficient identification of novel Hla-A* 0201-Presented Cytotoxic T Lymphocyte epitopes in the widely expressed tumor antigen prame by Proteasome-Mediated JH Kessler, NJ Beekman, SA Bres-Vloemans - The Journal of , 2001 - rupress.orghttps://rupress.org/jem/article-abstract/193/1/73/20096 Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches J Greiner, M Schmitt , L Li, K Giannopoulos, K Bosch - Blood, 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/108/13/4109/6594 Cytotoxic T lymphocytes directed to the Preferentially Expressed Antigen HE Heslop , CM Rooney , F Pane , B Savoldo - researchgate.nethttps://www.researchgate.net/profile/Luigia-Luciano/publication/5260894_Cytotoxic_T_lymphocytes_directed_to_the_preferentially_expressed_antigen_of_melanoma_PRAME_target_chronic_myeloid_leukemia/links/00b7d5278bb615a59f000000/Cytotoxic-T-lymphocytes-directed-to-the-preferentially-expressed-antigen-of-melanoma-PRAME-target-chronic-myeloid-leukemia.pdf Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia C Quintarelli, G Dotti, B De Angelis - Blood, The Journal , 2008 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/112/5/1876/25541

• Marke: Biosynth